Cigarette Smoke Exposure Induces Neurocognitive Impairments and Neuropathological Changes in the Hippocampus.
cigarette smoking
cognition
emphysema
microglia
neuroinflammation
synaptogenesis
Journal
Frontiers in molecular neuroscience
ISSN: 1662-5099
Titre abrégé: Front Mol Neurosci
Pays: Switzerland
ID NLM: 101477914
Informations de publication
Date de publication:
2022
2022
Historique:
received:
10
03
2022
accepted:
06
04
2022
entrez:
3
6
2022
pubmed:
4
6
2022
medline:
4
6
2022
Statut:
epublish
Résumé
Neurocognitive dysfunction is present in up to ∼61% of people with chronic obstructive pulmonary disease (COPD), with symptoms including learning and memory deficiencies, negatively impacting the quality of life of these individuals. As the mechanisms responsible for neurocognitive deficits in COPD remain unknown, we explored whether chronic cigarette smoke (CS) exposure causes neurocognitive dysfunction in mice and whether this is associated with neuroinflammation and an altered neuropathology. Male BALB/c mice were exposed to room air (sham) or CS (9 cigarettes/day, 5 days/week) for 24 weeks. After 23 weeks, mice underwent neurocognitive tests to assess working and spatial memory retention. At 24 weeks, mice were culled and lungs were collected and assessed for hallmark features of COPD. Serum was assessed for systemic inflammation and the hippocampus was collected for neuroinflammatory and structural analysis. Chronic CS exposure impaired lung function as well as driving pulmonary inflammation, emphysema, and systemic inflammation. CS exposure impaired working memory retention, which was associated with a suppression in hippocampal microglial number, however, these microglia displayed a more activated morphology. CS-exposed mice showed changes in astrocyte density as well as a reduction in synaptophysin and dendritic spines in the hippocampus. We have developed an experimental model of COPD in mice that recapitulates the hallmark features of the human disease. The altered microglial/astrocytic profiles and alterations in the neuropathology within the hippocampus may explain the neurocognitive dysfunction observed during COPD.
Sections du résumé
Background and Objective
UNASSIGNED
Neurocognitive dysfunction is present in up to ∼61% of people with chronic obstructive pulmonary disease (COPD), with symptoms including learning and memory deficiencies, negatively impacting the quality of life of these individuals. As the mechanisms responsible for neurocognitive deficits in COPD remain unknown, we explored whether chronic cigarette smoke (CS) exposure causes neurocognitive dysfunction in mice and whether this is associated with neuroinflammation and an altered neuropathology.
Methods
UNASSIGNED
Male BALB/c mice were exposed to room air (sham) or CS (9 cigarettes/day, 5 days/week) for 24 weeks. After 23 weeks, mice underwent neurocognitive tests to assess working and spatial memory retention. At 24 weeks, mice were culled and lungs were collected and assessed for hallmark features of COPD. Serum was assessed for systemic inflammation and the hippocampus was collected for neuroinflammatory and structural analysis.
Results
UNASSIGNED
Chronic CS exposure impaired lung function as well as driving pulmonary inflammation, emphysema, and systemic inflammation. CS exposure impaired working memory retention, which was associated with a suppression in hippocampal microglial number, however, these microglia displayed a more activated morphology. CS-exposed mice showed changes in astrocyte density as well as a reduction in synaptophysin and dendritic spines in the hippocampus.
Conclusion
UNASSIGNED
We have developed an experimental model of COPD in mice that recapitulates the hallmark features of the human disease. The altered microglial/astrocytic profiles and alterations in the neuropathology within the hippocampus may explain the neurocognitive dysfunction observed during COPD.
Identifiants
pubmed: 35656006
doi: 10.3389/fnmol.2022.893083
pmc: PMC9152421
doi:
Types de publication
Journal Article
Langues
eng
Pagination
893083Informations de copyright
Copyright © 2022 Dobric, De Luca, Seow, Wang, Brassington, Chan, Mou, Erlich, Liong, Selemidis, Spencer, Bozinovski and Vlahos.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Int J Chron Obstruct Pulmon Dis. 2015 Feb 02;10:261-76
pubmed: 25673984
Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8514-9
pubmed: 12824464
Brain Struct Funct. 2015 Jul;220(4):2027-42
pubmed: 24748560
J Neuroinflammation. 2020 Apr 27;17(1):133
pubmed: 32340626
Alzheimers Res Ther. 2015 Mar 21;7(1):32
pubmed: 25798202
Respir Res. 2017 Jun 19;18(1):123
pubmed: 28629359
Brain Res. 1998 Dec 7;813(2):303-12
pubmed: 9838173
Mar Drugs. 2019 Jan 03;17(1):
pubmed: 30609815
Proc Am Thorac Soc. 2005;2(4):258-66; discussion 290-1
pubmed: 16267346
Sci Rep. 2017 Nov 13;7(1):15454
pubmed: 29133824
Ann Thorac Med. 2011 Oct;6(4):221-6
pubmed: 21977068
Neuropsychopharmacology. 2017 Jul;42(8):1630-1639
pubmed: 28262740
Semin Immunopathol. 2016 Jul;38(4):497-515
pubmed: 27178410
Acta Neuropathol. 2010 Jan;119(1):7-35
pubmed: 20012068
J Nucl Med. 2020 Aug;61(8):1200-1204
pubmed: 32005773
Br J Pharmacol. 2021 Apr;178(8):1805-1818
pubmed: 33523477
Dis Model Mech. 2012 May;5(3):333-41
pubmed: 22279084
Neurobiol Aging. 2019 Feb;74:121-134
pubmed: 30448612
J Neuroendocrinol. 2020 Mar;32(3):e12838
pubmed: 32097992
J Bras Pneumol. 2015 Mar-Apr;41(2):182-90
pubmed: 25909154
PLoS One. 2014 Jul 17;9(7):e102468
pubmed: 25033379
J Neurosci. 2011 Nov 9;31(45):16241-50
pubmed: 22072675
Front Aging Neurosci. 2018 May 07;10:129
pubmed: 29867440
J Am Med Dir Assoc. 2017 May 1;18(5):420-426
pubmed: 28108209
Nature. 2017 Jan 26;541(7638):481-487
pubmed: 28099414
Toxicol Res. 2020 Feb 4;36(3):267-273
pubmed: 32685431
Fluids Barriers CNS. 2015 Jul 24;12:18
pubmed: 26206552
J Am Med Dir Assoc. 2014 Mar;15(3):214-219
pubmed: 24513227
JAMA Neurol. 2014 May;71(5):581-8
pubmed: 24637951
J Allergy Clin Immunol. 2013 Mar;131(3):752-62
pubmed: 23380220
Lung India. 2013 Jan;30(1):5-11
pubmed: 23661909
Am J Physiol Lung Cell Mol Physiol. 2010 Sep;299(3):L425-33
pubmed: 20511341
Am J Respir Cell Mol Biol. 2009 Dec;41(6):631-8
pubmed: 19717810
J Neuroimmunol. 2013 Jan 15;254(1-2):69-75
pubmed: 23031832
Sci Rep. 2016 Feb 15;6:20983
pubmed: 26877172
Am J Physiol Lung Cell Mol Physiol. 2006 May;290(5):L931-45
pubmed: 16361358
Prog Brain Res. 2007;163:3-22
pubmed: 17765709
Neurotherapeutics. 2010 Oct;7(4):354-65
pubmed: 20880500
Chest. 2013 Jul;144(1):119-127
pubmed: 23349026
Eur Respir J. 2019 Jul 18;54(1):
pubmed: 31196943
Am J Respir Cell Mol Biol. 2010 Apr;42(4):394-403
pubmed: 19502389
ERJ Open Res. 2019 May 28;5(2):
pubmed: 31149625
Am J Respir Cell Mol Biol. 2020 Feb;62(2):217-230
pubmed: 31461300
Eur Respir J. 2010 Apr;35(4):913-22
pubmed: 20356988
Clin Sci (Lond). 2014 Feb;126(4):253-65
pubmed: 24144354
J Immunol. 2012 Jul 15;189(2):946-55
pubmed: 22689883
PLoS One. 2012;7(5):e36752
pubmed: 22606286
Am J Physiol Lung Cell Mol Physiol. 2011 May;300(5):L691-700
pubmed: 21355040
Biomed Res Int. 2020 Jul 22;2020:7363712
pubmed: 32775438
Arch Clin Neuropsychol. 2021 Jul 19;36(5):acaa090 767 779-767
pubmed: 33103191
Respir Res. 2002;3:22
pubmed: 12204101
J Neurosci. 2018 Oct 10;38(41):8889-8904
pubmed: 30201764
Brain Behav Immun. 2013 Jan;27(1):22-32
pubmed: 22985767
J Neuroinflammation. 2020 Feb 7;17(1):52
pubmed: 32028971
J Clin Neurosci. 2006 May;13(4):457-65
pubmed: 16678725
PLoS One. 2014 Sep 10;9(9):e107591
pubmed: 25208214
Am J Respir Crit Care Med. 1998 Oct;158(4):1277-85
pubmed: 9769292
BMC Pulm Med. 2016 Feb 09;16:27
pubmed: 26861788
PLoS One. 2014 Sep 24;9(9):e107979
pubmed: 25250777
Neurobiol Learn Mem. 2015 May;121:20-9
pubmed: 25838119
Am J Respir Crit Care Med. 2017 Mar 1;195(5):557-582
pubmed: 28128970
BMC Public Health. 2021 Jun 30;21(1):1278
pubmed: 34193083
Cell. 2017 Aug 24;170(5):1000-1012.e19
pubmed: 28823555
Science. 2005 May 27;308(5726):1314-8
pubmed: 15831717
Am J Respir Cell Mol Biol. 2019 May;60(5):515-522
pubmed: 30339461
Br J Pharmacol. 2021 Apr;178(8):1869-1885
pubmed: 33609280
Exp Physiol. 2020 Sep;105(9):1459-1466
pubmed: 32666546
Proc Am Thorac Soc. 2008 May 1;5(4):475-7
pubmed: 18453358